|
Atomistry » Fluorine » PDB 3b0q-3cct » 3bel | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atomistry » Fluorine » PDB 3b0q-3cct » 3bel » |
Fluorine in PDB 3bel: X-Ray Structure of Egfr in Complex with Oxime InhibitorEnzymatic activity of X-Ray Structure of Egfr in Complex with Oxime Inhibitor
All present enzymatic activity of X-Ray Structure of Egfr in Complex with Oxime Inhibitor:
2.7.10.1; Protein crystallography data
The structure of X-Ray Structure of Egfr in Complex with Oxime Inhibitor, PDB code: 3bel
was solved by
M.C.Abad,
G.Xu,
M.P.Neeper,
G.T.Struble,
M.D.Gaul,
P.J.Connolly,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Fluorine Binding Sites:
The binding sites of Fluorine atom in the X-Ray Structure of Egfr in Complex with Oxime Inhibitor
(pdb code 3bel). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total only one binding site of Fluorine was determined in the X-Ray Structure of Egfr in Complex with Oxime Inhibitor, PDB code: 3bel: Fluorine binding site 1 out of 1 in 3belGo back to![]() ![]()
Fluorine binding site 1 out
of 1 in the X-Ray Structure of Egfr in Complex with Oxime Inhibitor
![]() Mono view ![]() Stereo pair view
Reference:
G.Xu,
L.L.Searle,
T.V.Hughes,
A.K.Beck,
P.J.Connolly,
M.C.Abad,
M.P.Neeper,
G.T.Struble,
B.A.Springer,
S.L.Emanuel,
R.H.Gruninger,
N.Pandey,
M.Adams,
S.Moreno-Mazza,
A.R.Fuentes-Pesquera,
S.A.Middleton,
L.M.Greenberger.
Discovery of Novel 4-Amino-6-Arylaminopyrimidine-5-Carbaldehyde Oximes As Dual Inhibitors of Egfr and Erbb-2 Protein Tyrosine Kinases. Bioorg.Med.Chem.Lett. V. 18 3495 2008.
Page generated: Mon Jul 14 15:19:10 2025
ISSN: ISSN 0960-894X PubMed: 18508264 DOI: 10.1016/J.BMCL.2008.05.024 |
Last articlesMg in 5GAEMg in 5G0R Mg in 5G5V Mg in 5G3T Mg in 5G5T Mg in 5G5S Mg in 5G4A Mg in 5G57 Mg in 5G50 Mg in 5G41 |
© Copyright 2008-2020 by atomistry.com | ||
Home | Site Map | Copyright | Contact us | Privacy |